5th Jan 2009 12:55
|
Press Release |
5 January 2009 |
Cyprotex Plc
("Cyprotex" or "the Company")
Directorate changes
Cyprotex PLC (AIM: CRX), the drug discovery technology and information company, announces today that Nikolas Sofronis and Russell Barry Gibbs have resigned as directors of the Company with effect from 31 December 2008.
Commenting on the resignations, Steve Harris, Chairman of Cyprotex said:
"Both Nikolas and Russell have made significant contributions to the development of Cyprotex over the years for which we are extremely grateful. I thank them on behalf of the Company and wish them well in the future. Cyprotex is actively seeking candidates for the Board vacancies created by their resignations."
- Ends -
For further information:
|
Cyprotex PLC |
|
|
Dr. Anthony Baxter, Chairman & Chief Executive Officer |
Tel: +44 (0) 1625 505 100 |
|
www.cyprotex.com |
|
Nomura Code Securities Limited |
|
|
Charles Walker, Corporate Finance |
Tel: +44 (0) 20 7776 1200 |
|
www.codesecurities.com |
Media enquiries:
|
Pelham PR |
|
|
Simon Miller |
Tel: +44 (0) 20 3178 4419 |
|
www.pelhampr.com |
Related Shares:
CRX.L